What are the major opportunities in the Familial Mediterranean Fever Pharmaceuticals market? What are the strategies for the Familial Mediterranean Fever Pharmaceuticals market?

For detailed insights on the major opportunities and strategies in the Familial Mediterranean Fever Pharmaceuticals market, Read More

How does the Familial Mediterranean Fever Pharmaceuticals market relate to the overall economy and other similar markets?

For detailed insights on Familial Mediterranean Fever Pharmaceuticals's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Familial Mediterranean Fever Pharmaceuticals market growth? SWOT analysis of the Familial Mediterranean Fever Pharmaceuticals market.

For detailed insights on the key dynamics influencing the Familial Mediterranean Fever Pharmaceuticals market growth and SWOT analysis of the Familial Mediterranean Fever Pharmaceuticals industry, Read More

Global Familial Mediterranean Fever Pharmaceuticals Market Report 2025

Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Familial Mediterranean Fever Pharmaceuticals Global Market Report 2025

Name: Familial Mediterranean Fever Pharmaceuticals Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Drug Type (Colchicine, Interleukin-1 Inhibitors, Anti-IL-6 Drugs), By Route Of Administration (Oral, Injectable), By End Users (Hospitals, Clinical Diagnostic Laboratories, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Familial Mediterranean Fever Pharmaceuticals Market Overview

• Familial Mediterranean Fever Pharmaceuticals market size has reached to $1.64 billion in 2024

• Expected to grow to $2.1 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%

• Growth Driver: Rise In Gene Therapy Driving The Growth Of The Market Due To Advancements In Genetic Engineering

• Market Trend: Advancements In Treatments Focus On Cost-Effective Alternatives And Innovative Therapies To Improve Patient Outcomes

• Middle East was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Familial Mediterranean Fever Pharmaceuticals Market?

Familial mediterranean fever (FMF) pharmaceuticals refer to medications used to manage and treat FMF, a genetic disorder characterized by recurrent fever and inflammation, often affecting the abdomen, chest, and joints. The primary goal of these pharmaceuticals is to reduce the frequency and severity of attacks and prevent long-term complications, such as amyloidosis.

The main familial mediterranean fever pharmaceuticals are colchicine, Interleukin-1 Inhibitors, and anti-il-6 drugs. Colchicine is a medication that helps reduce inflammation and prevent flare-ups in conditions like gout and other inflammatory disorders. It can be administered through both oral and injectable channels and is used by various end users including hospitals, clinical diagnostic laboratories, and others.

Familial Mediterranean Fever Pharmaceuticals Market Size and growth rate 2025 to 2029: Graph

What Is The Familial Mediterranean Fever Pharmaceuticals Market Size 2025 And Growth Rate?

What Is The Familial Mediterranean Fever Pharmaceuticals Market Growth Forecast?

The familial mediterranean fever pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $2.1 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increase in the adoption of advanced cancer therapeutic options, growing interest in gene therapy and biologics, rise in adoption of advanced therapy, inflating utilization of effective medications, and widespread adoption of supportive therapies. Major trends in the forecast period include advancements in treatment, introduction of newer drug classes, collaboration between academic institutions, research organizations, and pharmaceutical companies, adaptation of new therapeutics, and development in technology.

The forecast of 5.1% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade restrictions could hinder U.S. autoinflammatory disease management by inflating prices of colchicine APIs and genetic testing kits sourced from Israel and Turkey, resulting in delayed treatment initiation and higher rheumatology medication expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Familial Mediterranean Fever Pharmaceuticals Market Segmented?

1) By Drug Type: Colchicine, Interleukin-1 Inhibitors, Anti-IL-6 Drugs

2) By Route Of Administration: Oral, Injectable

3) By End Users: Hospitals, Clinical Diagnostic Laboratories, Other End Users

Subsegments:

1) By Colchicine: Oral Colchicine, Intravenous Colchicine

2) By Interleukin-1 Inhibitors: Anakinra, Canakinumab, Rilonacept

3) By Anti-IL-6 Drugs: Tocilizumab, Sarilumab, Siltuximab

What Is Driving The Familial Mediterranean Fever Pharmaceuticals Market? Rise In Gene Therapy Driving The Growth Of The Market Due To Advancements In Genetic Engineering

The rise in gene therapy is expected to drive the growth of the familial Mediterranean fever (FMF) pharmaceuticals market going forward. Gene therapy is a medical approach that modifies or replaces faulty genes to treat or prevent diseases at the genetic level. The rise in gene therapy is due to advancements in genetic engineering, which enable precise targeting and correction of genetic disorders, offering potential cures for previously untreatable diseases. Gene therapy positively impacts familial mediterranean fever (FMF) pharmaceuticals by targeting the root cause mutations in the MEFV (Mediterranean fever) gene, potentially providing a long-term or permanent cure rather than symptom management. For instance, in July 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit organization, 76 gene therapy trials were initiated in the second quarter of 2024, a 25% increase from the previous quarter. Therefore, the rise in gene therapy is driving the growth of the familial Mediterranean fever (FMF) pharmaceuticals market.

Who Are The Major Players In The Global Familial Mediterranean Fever Pharmaceuticals Market?

Major companies operating in the familial mediterranean fever pharmaceuticals market are Merck & Co. Inc., Bristol Myers Squibb, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc., Swedish Orphan Biovitrum AB (Sobi), Granules Pharmaceuticals Inc., Sanmar Group, Indena S.p.A., Harman Finochem, Camber Pharmaceuticals Inc., R-Pharm Group, Alchem International, AdvaCare Pharma USA LLC, ViennaLab Diagnostics GmbH, Honour Lab Ltd., Vital Laboratories Pvt. Ltd., Enomark Biotech Pvt. Ltd., Gonane Pharma, Ennature Biopharma

What Are The Key Trends Of The Global Familial Mediterranean Fever Pharmaceuticals Market? Advancements In Treatments Focus On Cost-Effective Alternatives And Innovative Therapies To Improve Patient Outcomes

Major companies operating in the familial mediterranean fever (FMF) pharmaceuticals market are focusing on developing advanced treatments, such as cost-effective generic alternatives, to explore novel biologics and gene therapies. A cost-effective generic alternative is a lower-cost version of a brand-name drug that maintains the same active ingredients, dosage, safety, and effectiveness. For instance, in January 2022, Camber Pharmaceuticals Inc., a US-based pharmaceutical manufacturing company, launched generic Colcrys (colchicine) tablets, expanding its product portfolio. These tablets are used for treating and preventing familial mediterranean fever (FMF) in adults and children aged four and older and for managing gout flares. Available in 0.6 mg strength, they come in 30- and 100-count bottles. This launch supports Camber’s commitment to delivering high-quality, affordable generic medications to enhance patient care.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Familial Mediterranean Fever Pharmaceuticals Market? Sobi Partners With Acino For Exclusive Distribution Of Rare Disease Treatments In Kazakhstan

In January 2024, Swedish Orphan Biovitrum AB, a Sweden-based manufacturer of Interleukin-1 inhibitors, partnered with Acino International AG. The partnership enables Acino to distribute Sobi’s specialized rare disease treatments exclusively in Kazakhstan, expanding access to innovative therapies. Acino International AG is a Switzerland-based pharmaceutical company specializing in developing, manufacturing, and distributing high-quality generic and specialty medicines.

What Is The Regional Outlook For The Global Familial Mediterranean Fever Pharmaceuticals Market?

Middle East was the largest region in the familial mediterranean fever pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Familial Mediterranean Fever Pharmaceuticals Market?

The familial mediterranean fever pharmaceuticals market consists of sales of NSAIDs, corticosteroids, immunosuppressants, disease-modifying antirheumatic drugs, and pain management medications used to manage inflammation and prevent complications in familial mediterranean fever patients. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Familial Mediterranean Fever Pharmaceuticals Industry?

The familial mediterranean fever pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the familial mediterranean fever pharmaceuticals industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Familial Mediterranean Fever Pharmaceuticals Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.72 billion
Revenue Forecast In 2034	$2.1 billion
Growth Rate	CAGR of 5.1% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The familial mediterranean fever pharmaceuticals market covered in this report is segmented – 1) By Drug Type: Colchicine, Interleukin-1 Inhibitors, Anti-IL-6 Drugs 2) By Route Of Administration: Oral, Injectable 3) By End Users: Hospitals, Clinical Diagnostic Laboratories, Other End Users Subsegments: 1) By Colchicine: Oral Colchicine, Intravenous Colchicine 2) By Interleukin-1 Inhibitors: Anakinra, Canakinumab, Rilonacept 3) By Anti-IL-6 Drugs: Tocilizumab, Sarilumab, Siltuximab
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Request for Sample
Customization Scope	Explore Purchase Options
Pricing And Purchase Options

1. Executive Summary

2. Familial Mediterranean Fever Pharmaceuticals Market Characteristics

3. Familial Mediterranean Fever Pharmaceuticals Market Trends And Strategies

4. Familial Mediterranean Fever Pharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Familial Mediterranean Fever Pharmaceuticals Growth Analysis And Strategic Analysis Framework

5.1. Global Familial Mediterranean Fever Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Familial Mediterranean Fever Pharmaceuticals Market Growth Rate Analysis

5.4. Global Familial Mediterranean Fever Pharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Familial Mediterranean Fever Pharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Familial Mediterranean Fever Pharmaceuticals Total Addressable Market (TAM)

6. Familial Mediterranean Fever Pharmaceuticals Market Segmentation

6.1. Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Colchicine

Interleukin-1 Inhibitors

Anti-IL-6 Drugs

6.2. Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Injectable

6.3. Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinical Diagnostic Laboratories

Other End Users

6.4. Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Colchicine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Colchicine

Intravenous Colchicine

6.5. Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Interleukin-1 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anakinra

Canakinumab

Rilonacept

6.6. Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Anti-IL-6 Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tocilizumab

Sarilumab

Siltuximab

7. Familial Mediterranean Fever Pharmaceuticals Market Regional And Country Analysis

7.1. Global Familial Mediterranean Fever Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Familial Mediterranean Fever Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Familial Mediterranean Fever Pharmaceuticals Market

8.1. Asia-Pacific Familial Mediterranean Fever Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Familial Mediterranean Fever Pharmaceuticals Market

9.1. China Familial Mediterranean Fever Pharmaceuticals Market Overview

9.2. China Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Familial Mediterranean Fever Pharmaceuticals Market

10.1. India Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Familial Mediterranean Fever Pharmaceuticals Market

11.1. Japan Familial Mediterranean Fever Pharmaceuticals Market Overview

11.2. Japan Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Familial Mediterranean Fever Pharmaceuticals Market

12.1. Australia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Familial Mediterranean Fever Pharmaceuticals Market

13.1. Indonesia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Familial Mediterranean Fever Pharmaceuticals Market

14.1. South Korea Familial Mediterranean Fever Pharmaceuticals Market Overview

14.2. South Korea Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Familial Mediterranean Fever Pharmaceuticals Market

15.1. Western Europe Familial Mediterranean Fever Pharmaceuticals Market Overview

15.2. Western Europe Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Familial Mediterranean Fever Pharmaceuticals Market

16.1. UK Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Familial Mediterranean Fever Pharmaceuticals Market

17.1. Germany Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Familial Mediterranean Fever Pharmaceuticals Market

18.1. France Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Familial Mediterranean Fever Pharmaceuticals Market

19.1. Italy Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Familial Mediterranean Fever Pharmaceuticals Market

20.1. Spain Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Familial Mediterranean Fever Pharmaceuticals Market

21.1. Eastern Europe Familial Mediterranean Fever Pharmaceuticals Market Overview

21.2. Eastern Europe Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Familial Mediterranean Fever Pharmaceuticals Market

22.1. Russia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Familial Mediterranean Fever Pharmaceuticals Market

23.1. North America Familial Mediterranean Fever Pharmaceuticals Market Overview

23.2. North America Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Familial Mediterranean Fever Pharmaceuticals Market

24.1. USA Familial Mediterranean Fever Pharmaceuticals Market Overview

24.2. USA Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Familial Mediterranean Fever Pharmaceuticals Market

25.1. Canada Familial Mediterranean Fever Pharmaceuticals Market Overview

25.2. Canada Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Familial Mediterranean Fever Pharmaceuticals Market

26.1. South America Familial Mediterranean Fever Pharmaceuticals Market Overview

26.2. South America Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Familial Mediterranean Fever Pharmaceuticals Market

27.1. Brazil Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Familial Mediterranean Fever Pharmaceuticals Market

28.1. Middle East Familial Mediterranean Fever Pharmaceuticals Market Overview

28.2. Middle East Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Familial Mediterranean Fever Pharmaceuticals Market

29.1. Africa Familial Mediterranean Fever Pharmaceuticals Market Overview

29.2. Africa Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Familial Mediterranean Fever Pharmaceuticals Market Competitive Landscape And Company Profiles

30.1. Familial Mediterranean Fever Pharmaceuticals Market Competitive Landscape

30.2. Familial Mediterranean Fever Pharmaceuticals Market Company Profiles

30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bristol Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Familial Mediterranean Fever Pharmaceuticals Market Other Major And Innovative Companies

31.1. Swedish Orphan Biovitrum AB (Sobi)

31.2. Granules Pharmaceuticals Inc.

31.3. Sanmar Group

31.4. Indena S.p.A.

31.5. Harman Finochem

31.6. Camber Pharmaceuticals Inc.

31.7. R-Pharm Group

31.8. Alchem International

31.9. AdvaCare Pharma USA LLC

31.10. ViennaLab Diagnostics GmbH

31.11. Honour Lab Ltd.

31.12. Vital Laboratories Pvt. Ltd.

31.13. Enomark Biotech Pvt. Ltd.

31.14. Gonane Pharma

31.15. Ennature Biopharma

32. Global Familial Mediterranean Fever Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Familial Mediterranean Fever Pharmaceuticals Market

34. Recent Developments In The Familial Mediterranean Fever Pharmaceuticals Market

35. Familial Mediterranean Fever Pharmaceuticals Market High Potential Countries, Segments and Strategies

35.1 Familial Mediterranean Fever Pharmaceuticals Market In 2029 - Countries Offering Most New Opportunities

35.2 Familial Mediterranean Fever Pharmaceuticals Market In 2029 - Segments Offering Most New Opportunities

35.3 Familial Mediterranean Fever Pharmaceuticals Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Colchicine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Interleukin-1 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Anti-IL-6 Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Familial Mediterranean Fever Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Familial Mediterranean Fever Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Merck & Co. Inc. Financial Performance

Table 78: Bristol Myers Squibb Financial Performance

Table 79: Novartis International AG Financial Performance

Table 80: Takeda Pharmaceutical Company Limited Financial Performance

Table 81: Amgen Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Colchicine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Interleukin-1 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Anti-IL-6 Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Familial Mediterranean Fever Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Familial Mediterranean Fever Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Merck & Co. Inc. Financial Performance

Figure 78: Bristol Myers Squibb Financial Performance

Figure 79: Novartis International AG Financial Performance

Figure 80: Takeda Pharmaceutical Company Limited Financial Performance

Figure 81: Amgen Inc. Financial Performance

2025 Over-The-Counter (OTC) Diet Products Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Parathyroid Disease Treatment Market Revenue Outlook: Strategic Insights and Forecast to 2029

Industry Forecast: PCSK9 Inhibitor Market to Generate $6.87 Billion Revenue by 2029

CAGR of 5.4% Projected for Pediatric Asthma Treatment Market From 2025 to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Anticoccidial Drugs Global Market Report 2025 – By Drug Class (Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes), By Drug Action (Coccidiostatic, Coccidiocidal), By Application (Poultry, Swin...

Infectious Disease Therapeutics Global Market Report 2025 – By Type (Drugs, Vaccines), By Disease (Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases), By End-User (Hospitals And Clinics, Retail Pharmacies, Res...

Veterinary Pharmaceuticals Global Market Report 2025 – By Type (Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals), By Type Of Animal (Livestock, Companion Animals), ...

Pharmaceutical Label Global Market Report 2025 – By Type (Pressure-Sensitive Label, Glue-Applied Label, Sleeve Label, In-Mold Label, Other Types), By Material (Paper, Polymer Film, Other Materials), By Application (Instr...

Pediatric Supplements Global Market Report 2025 – By Product Type (Vitamins, Minerals, Probiotics, Omega-3 Fatty Acids, Amino Acids, Other Product Types), By Form (Gummies, Chewable, Liquids, Powders, Tablets, Other Form...

Veterinary Pharmaceuticals Global Market Report 2025 – By Type (Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals), By Type Of Animal (Livestock, Companion Animals), ...

Pharmaceuticals Market - By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective...

Frequently Asked Questions

What is the definition of the Familial Mediterranean Fever Pharmaceuticals market?

How will the Familial Mediterranean Fever Pharmaceuticals market drivers and restraints affect the market dynamics? What forces will shape the Familial Mediterranean Fever Pharmaceuticals industry going forward?

The market major growth driver - Rise In Gene Therapy Driving The Growth Of The Market Due To Advancements In Genetic Engineering. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Familial Mediterranean Fever Pharmaceuticals market?

The familial mediterranean fever pharmaceuticals market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.72 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to rise in the disease prevalence, rise in the migration, rise in the geriatric population, increasing cases of genetic aberrations within the MEFV gene, and rise in genetic mutation. The familial mediterranean fever pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to " $2.1 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increase in the adoption of advanced cancer therapeutic options, growing interest in gene therapy and biologics, rise in adoption of advanced therapy, inflating utilization of effective medications, and widespread adoption of supportive therapies. Major trends in the forecast period include advancements in treatment, introduction of newer drug classes, collaboration between academic institutions, research organizations, and pharmaceutical companies, adaptation of new therapeutics, and development in technology. For further insights on this market, request a sample here

How is the Familial Mediterranean Fever Pharmaceuticals market segmented?

The familial mediterranean fever pharmaceuticals market covered in this report is segmented –
1) By Drug Type: Colchicine, Interleukin-1 Inhibitors, Anti-IL-6 Drugs
2) By Route Of Administration: Oral, Injectable
3) By End Users: Hospitals, Clinical Diagnostic Laboratories, Other End Users Subsegments:
1) By Colchicine: Oral Colchicine, Intravenous Colchicine
2) By Interleukin-1 Inhibitors: Anakinra, Canakinumab, Rilonacept
3) By Anti-IL-6 Drugs: Tocilizumab, Sarilumab, Siltuximab For further insights on this market, request a sample here

Which region has the largest share of the Familial Mediterranean Fever Pharmaceuticals market? What are the other regions covered in the report?

Middle East was the largest region in the familial mediterranean fever pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the familial mediterranean fever pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Familial Mediterranean Fever Pharmaceuticals market?

What are the key trends in the Familial Mediterranean Fever Pharmaceuticals market?

Major trends in this market include Advancements In Treatments Focus On Cost-Effective Alternatives And Innovative Therapies To Improve Patient Outcomes. For further insights on this market, request a sample here.